These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 9070519

  • 21. Coagulation activation markers in the prediction of venous thrombosis after elective hip surgery.
    Cofrancesco E, Cortellaro M, Corradi A, Ravasi F, Bertocchi F.
    Thromb Haemost; 1997 Feb; 77(2):267-9. PubMed ID: 9157579
    [Abstract] [Full Text] [Related]

  • 22. New therapeutic options in deep vein thrombosis prophylaxis.
    Eriksson BI.
    Semin Hematol; 2000 Jul; 37(3 Suppl 5):7-9. PubMed ID: 11055889
    [Abstract] [Full Text] [Related]

  • 23. Prophylaxis for the prevention of venous thromboembolism after total knee arthroplasty. A comparison between unfractionated and low-molecular-weight heparin.
    Faunø P, Suomalainen O, Rehnberg V, Hansen TB, Krøner K, Soimakallio S, Nielsen E.
    J Bone Joint Surg Am; 1994 Dec; 76(12):1814-8. PubMed ID: 7989386
    [Abstract] [Full Text] [Related]

  • 24. Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement.
    Planes A, Vochelle N, Mazas F, Mansat C, Zucman J, Landais A, Pascariello JC, Weill D, Butel J.
    Thromb Haemost; 1988 Dec 22; 60(3):407-10. PubMed ID: 2853459
    [Abstract] [Full Text] [Related]

  • 25. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trial.
    Warwick D, Harrison J, Glew D, Mitchelmore A, Peters TJ, Donovan J.
    J Bone Joint Surg Am; 1998 Aug 22; 80(8):1158-66. PubMed ID: 9730125
    [Abstract] [Full Text] [Related]

  • 26. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
    Beisaw NE, Comerota AJ, Groth HE, Merli GJ, Weitz HH, Zimmerman RC, Diserio FJ, Sasahara AA.
    J Bone Joint Surg Am; 1988 Jan 22; 70(1):2-10. PubMed ID: 3275673
    [Abstract] [Full Text] [Related]

  • 27. Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis.
    Frame JN, Rice L, Bartholomew JR, Whelton A.
    Clin Ther; 2010 Apr 22; 32(4):626-36. PubMed ID: 20435232
    [Abstract] [Full Text] [Related]

  • 28. Subcutaneous low-molecular weight heparin or oral anticoagulants for the prevention of deep-vein thrombosis in elective hip and knee replacement? Fraxiparine Oral Anticoagulant Study Group.
    Hamulyák K, Lensing AW, van der Meer J, Smid WM, van Ooy A, Hoek JA.
    Thromb Haemost; 1995 Dec 22; 74(6):1428-31. PubMed ID: 8772214
    [Abstract] [Full Text] [Related]

  • 29. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
    Bergmann JF, Neuhart E.
    Thromb Haemost; 1996 Oct 22; 76(4):529-34. PubMed ID: 8902991
    [Abstract] [Full Text] [Related]

  • 30. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement.
    Avikainen V, von Bonsdorff H, Partio E, Kaira P, Hakkinen S, Usenius JP, Kaaja R.
    Ann Chir Gynaecol; 1995 Oct 22; 84(1):85-90. PubMed ID: 7645915
    [Abstract] [Full Text] [Related]

  • 31. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement.
    Bergqvist D, Benoni G, Björgell O, Fredin H, Hedlundh U, Nicolas S, Nilsson P, Nylander G.
    N Engl J Med; 1996 Sep 05; 335(10):696-700. PubMed ID: 8703168
    [Abstract] [Full Text] [Related]

  • 32. The occurrence of antibodies to heparin-platelet factor 4 in cardiac and thoracic surgical patients receiving desirudin or heparin for postoperative venous thrombosis prophylaxis.
    Avidan MS, Smith JR, Skrupky LP, Hill L, Jacobsohn E, Burnside B, Tymkew H, Eby C, Damiano R, Despotis GJ.
    Thromb Res; 2011 Dec 05; 128(6):524-9. PubMed ID: 21794899
    [Abstract] [Full Text] [Related]

  • 33. The prevention of postoperative deep vein thrombosis and pulmonary embolism with low dose subcutaneous heparin and dextran.
    Verstraete M.
    Surg Gynecol Obstet; 1976 Dec 05; 143(6):981-5. PubMed ID: 996722
    [Abstract] [Full Text] [Related]

  • 34. Safety of desirudin in thrombosis prevention after total knee arthroplasty: the DESIR-ABLE study.
    Jove M, Maslanka M, Minkowitz HS, Jaffer AK, DESIR-ABLE Investigators.
    Am J Ther; 2014 Dec 05; 21(6):496-9. PubMed ID: 23344102
    [Abstract] [Full Text] [Related]

  • 35. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group.
    Br J Surg; 1988 Nov 05; 75(11):1058-63. PubMed ID: 2905187
    [Abstract] [Full Text] [Related]

  • 36. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
    Ugaki H, Enomoto T, Fujiwara K, Kimura T, Kawasaki T.
    Blood Coagul Fibrinolysis; 2008 Sep 05; 19(6):585-9. PubMed ID: 18685443
    [Abstract] [Full Text] [Related]

  • 37. Multicenter trial of desirudin for the prophylaxis of thrombosis: an alternative to heparin-based anticoagulation (DESIR-ABLE).
    Bergese SD, Minkowitz HS, Arpino PA, Sane DC, Levy JH.
    Clin Appl Thromb Hemost; 2013 Sep 05; 19(4):418-23. PubMed ID: 22802554
    [Abstract] [Full Text] [Related]

  • 38. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
    Boyce SW, Bandyk DF, Bartholomew JR, Frame JN, Rice L.
    Am J Ther; 2011 Jan 05; 18(1):14-22. PubMed ID: 21079512
    [Abstract] [Full Text] [Related]

  • 39. [Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II].
    Ganzer D, Gutezeit A, Mayer G, Greinacher A, Eichler P.
    Z Orthop Ihre Grenzgeb; 1997 Jan 05; 135(6):543-9. PubMed ID: 9499523
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.